Skip to main content

Table 1 Patient clinical characteristics

From: Chidamide and venetoclax synergistically exert cytotoxicity on multiple myeloma by upregulating BIM expression

Number

Gender

Age

Disease

Isotype

FISH in diagnosed

Patient#1

Male

40

Newly diagnosed MM

IgG, kappa

17p-, t (4,14)

Patient#2

Male

63

RRMM

IgA, kappa

1q21

Patient#3

Female

73

RRMM

IgG, lamda

14q32, 1q21